SCHEMBL23950691

SCHEMBL23950691

Nc1c(C(=O)O)cc(-c2ccc(C(F)(F)F)cc2)nc1-c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.52
▸ MAPT P10636 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ XBP1 P17861 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ S1PR1 P21453 1/20 0.46
▸ NTRK1 P04629 1/20 0.45
▸ SCN9A Q15858 1/20 0.45
▸ KDR P35968 2/20 0.43
▸ SORT1 Q99523 1/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ PARP1 P09874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30101970 1.00 DHODH (0.52) DHODHMAPTLMNAXBP1SMN1; SMN2
SCHEMBL23390311 0.87 DHODH (0.47) DHODHLMNAKDM4EHTT
SCHEMBL30101958 0.82 MAPT (0.45) MAPTLMNAXBP1SMN1; SMN2NPSR1
SCHEMBL23951108 0.82 MAPT (0.45) MAPTLMNAXBP1SMN1; SMN2NPSR1
SCHEMBL23951132 0.82 MAPT (0.45) MAPTLMNAXBP1SMN1; SMN2NPSR1
SCHEMBL23390607 0.79 KMT2A (0.47) KMT2ARXFP1
SCHEMBL28761425 0.78 CHEK1 (0.45) MAPTTP53POLBKDM4EKDR
SCHEMBL21001306 0.78 KMO (0.50) DHODHMAPTLMNAXBP1SMN1; SMN2
SCHEMBL25404965 0.77 AHR (0.52) DHODHMAPTKDR
SCHEMBL23390095 0.76 CFTR (0.53) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2023-05-11 — — US disclosed
WO-2021210970-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS DONG-A ST CO., LTD. (KR) 2021-10-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230147257-A1 PYRIDOPYRIMIDINONE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, AIPL1 DHODH 1409/4885MAPT 4052/4885LMNA 3455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback